From: Survival of cancer patients with pre-existing heart disease
Survival time/type | Pre-existing cardiovascular diseases | All cancer (ex NMSC) | Colorectal cancer | Lung cancer | Female breast cancer | Prostate cancer |
---|---|---|---|---|---|---|
One-year observed survival (95% CI) | No | 74.7% (74.2%, 75.2%) | 79.9% (78.5%, 81.2%) | 34.7% (33.0%, 36.4%) | 95.7% (95.1%, 96.3%) | 95.3% (94.5%, 95.9%) |
Yes | 53.6% (52.5%, 54.7%) | 68.1% (65.3%, 70.7%) | 27.6% (25.4%, 29.9%) | 83.9% (80.4%, 86.8%) | 86.8% (84.5%, 88.8%) | |
Five-year observed survival (95% CI) | No | 54.6% (54.0%, 55.2%) | 56.1% (54.4%, 57.7%) | 11.4% (10.3%, 12.5%) | 80.5% (79.3%, 81.6%) | 77.1% (75.6%, 78.5%) |
Yes | 28.2% (27.2%, 29.2%) | 37.7% (34.9%, 40.5%) | 6.4% (5.3%, 7.8%) | 48.7% (44.3%, 53.0%) | 56.5% (53.3%, 59.6%) | |
One-year cancer specific survival (95% CI) | No | 76.9% (76.3%, 77.4%) | 82.0% (80.7%, 83.3%) | 36.9% (35.2%, 38.6%) | 96.5% (95.9%, 97.0%) | 96.9% (96.3%, 97.5%) |
Yes | 58.8% (57.7%, 60.0%) | 74.6% (71.9%, 77.0%) | 30.9% (28.5%, 33.3%) | 89.2% (86.1%, 91.6%) | 91.8% (89.9%, 93.4%) | |
Five-year cancer specific survival (95% CI) | No | 59.6% (59.0%, 60.2%) | 60.8% (59.2%, 62.4%) | 13.8% (12.6%, 15.1%) | 85.0% (83.9%, 86.0%) | 83.8% (82.5%, 85.1%) |
Yes | 39.0% (37.8%, 40.2%) | 50.9% (47.8%, 54.0%) | 9.3% (7.8%, 11.1%) | 70.1% (65.6%, 74.2%) | 73.1% (70.0%, 76.0%) | |
Proportion who died from cardiovascular diseases after five-years (95% CI) | No | 1.7% (1.5%, 1.9%) | 1.8% (1.4%, 2.5%) | 3.4% (2.2%, 5.1%) | 1.1% (0.8%, 1.5%) | 1.9% (1.4%, 2.4%) |
Yes | 10.0% (9.0%, 11.0%) | 9.7% (7.7%, 12.2%) | 9.8% (6.8%, 14.2%) | 10.8% (8.0%, 14.4%) | 8.0% (6.2%, 10.2% |